Prophylactic Cholecystectomy at Time of Surgery for Small Bowel Neuroendocrine Tumor Does Not Increase Postoperative Morbidity

Keyphrases

• Postoperative Morbidity 100%
• Timing of Surgery 100%
• Cholecystectomy 100%
• Risk Difference 20%
• Tumor Resection 20%
• High Mortality 10%
• Non-associated 10%
• Confounding 10%
• Associated Complications 10%
• Multivariable 10%
• Confidence Interval 10%
• Baseline Characteristics 10%
• Resection 10%
• Operative Time 10%
• Duodenum 10%
• Cholestasis 10%
• High Morbidity 10%
• American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) 10%
• Disseminated Cancer 10%
• Associated Morbidity 10%
• Somatostatin Analog Therapy 10%

Medicine and Dentistry

• Cholecystectomy 100%
• Neuroendocrine Tumor 100%
• Cancer Surgery 16%
• Attributable Risk 16%
• Prospective Study 8%
• Operation Duration 8%
• Surgeon 8%
• Quality Improvement 8%
• Cholestasis 8%
• Duodenum 8%
• Somatostatin Derivative 8%
• Surgery 8%
• Disseminated Cancer 8%